AXIM BIOTECHNOLOGIES, INC. Other Asset Impairment Charges
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Other Asset Impairment Charges of $5.85 million for the 9-month period ending 2022-09-30, per its 10-Q/A filed 2022-11-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2022-11-15
- AXIM BIOTECHNOLOGIES, INC. other asset impairment charges for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. other asset impairment charges for the quarter ending 2022-03-31 was $5.85M, a 0.00% change year-over-year.
- AXIM BIOTECHNOLOGIES, INC. other asset impairment charges for the quarter ending 2021-06-30 was $5.85M.
- AXIM BIOTECHNOLOGIES, INC. other asset impairment charges for the quarter ending 2021-03-31 was $5.85M.
| Period end | Other Asset Impairment Charges 3 month | Other Asset Impairment Charges 6 month | Other Asset Impairment Charges 9 month | Other Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2022-09-30 | $5.85M 10-Q/A · filed 2022-11-15 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-16 | $5.85M 10-Q · filed 2022-08-16 | ||
| 2022-03-31 | $5.85M 10-Q · filed 2022-05-23 | |||
| 2021-12-31 | $5.85M 10-Q/A · filed 2022-11-15 | |||
| 2021-06-30 | $5.85M 10-Q · filed 2022-08-16 | $11.70M derived: sum of 2 quarters · filed 2022-08-16 | ||
| 2021-03-31 | $5.85M 10-Q · filed 2022-05-23 |